NCT00745433View on ClinicalTrials.gov

Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide

CompletedOBSERVATIONAL
Enrollment

906

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

repaglinide

Start dose and frequency at the discretion of the physician following clinical practice

DRUG

metformin

Start dose and frequency at the discretion of the physician following clinical practice

Trial Locations (1)

1070

Brussels

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY